5Lemley KV,Abdullah I,Myers BD,et al.Evolution of incipient nephropathy in type 2 diabetes mellitus[J].Kidey Int,2000,58(3):1228.
6Lemley KV, Abdullah I, Myers BD, et al. Evolution of incipient nephropathy in type 2 diabetes mellilus. Kidey lnt,2000,58 (3) : 1228.
7Prasad D. Neutrophil gelatinase-associated lipocalin-an emerging troponin for kidney injury[J]. Nephrol Dial Transplant, 2008, 23(17): 3737-3743.
8Bolignano D , Donato V , Coppolino G, et al. Neutro- phil gelatinase- associated lipocalin (NGAL) as a marker of kidney damage[J].Am J Kidney Dis , 2008 , 52(3) : 595-605.
9Bolignano D, Lacquaniti A, Coppolino G, et al. Neu- trophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients[J]. Kid- ney Blood Press Res, 2009, 32(18)c 91-98.
10Macisaac RJ, Tsalamandris C, Thomas MC,et al. Es- timating glomerularfiltration rate in diabetes: a com- parison of cystatin-C and creatinine-based methods[J]. Diabetologia, 2006, 49(12): 1686-1689.